
Praxis Precision Medicines Inc
NASDAQ:PRAX

Balance Sheet
Balance Sheet Decomposition
Praxis Precision Medicines Inc
Current Assets | 404.4m |
Cash & Short-Term Investments | 392.6m |
Other Current Assets | 11.8m |
Non-Current Assets | 78.7m |
Long-Term Investments | 77m |
PP&E | 1.4m |
Other Non-Current Assets | 416k |
Balance Sheet
Praxis Precision Medicines Inc
Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
---|---|---|---|---|---|---|---|---|
Assets | ||||||||
Cash & Cash Equivalents |
18
|
45
|
297
|
139
|
62
|
81
|
215
|
|
Cash Equivalents |
18
|
45
|
297
|
139
|
62
|
81
|
215
|
|
Short-Term Investments |
0
|
0
|
0
|
137
|
39
|
0
|
177
|
|
Other Current Assets |
1
|
1
|
6
|
12
|
10
|
4
|
12
|
|
Total Current Assets |
19
|
46
|
302
|
287
|
111
|
85
|
404
|
|
PP&E Net |
0
|
2
|
1
|
5
|
4
|
3
|
1
|
|
PP&E Gross |
0
|
2
|
1
|
5
|
4
|
3
|
1
|
|
Accumulated Depreciation |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
77
|
|
Other Long-Term Assets |
1
|
1
|
0
|
1
|
0
|
0
|
0
|
|
Total Assets |
20
N/A
|
48
+141%
|
303
+536%
|
293
-3%
|
115
-61%
|
88
-24%
|
483
+449%
|
|
Liabilities | ||||||||
Accounts Payable |
3
|
3
|
4
|
11
|
15
|
6
|
13
|
|
Accrued Liabilities |
2
|
4
|
12
|
28
|
17
|
9
|
25
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Liabilities |
0
|
0
|
0
|
0
|
3
|
1
|
0
|
|
Total Current Liabilities |
5
|
7
|
16
|
38
|
34
|
16
|
38
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
0
|
1
|
0
|
4
|
5
|
3
|
0
|
|
Total Liabilities |
5
N/A
|
8
+49%
|
16
+107%
|
42
+167%
|
39
-7%
|
18
-53%
|
38
+106%
|
|
Equity | ||||||||
Common Stock |
56
|
121
|
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
41
|
81
|
150
|
317
|
531
|
654
|
837
|
|
Additional Paid In Capital |
0
|
0
|
437
|
568
|
607
|
724
|
1 282
|
|
Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
Total Equity |
15
N/A
|
40
+173%
|
288
+617%
|
251
-13%
|
76
-70%
|
70
-8%
|
445
+539%
|
|
Total Liabilities & Equity |
20
N/A
|
48
+141%
|
303
+536%
|
293
-3%
|
115
-61%
|
88
-24%
|
483
+449%
|
|
Shares Outstanding | ||||||||
Common Shares Outstanding |
34
|
34
|
38
|
45
|
49
|
9
|
19
|